WAVE Life Sciences (WVE)
5.73
-0.36 (5.91%)
Upcoming Events
Latest Headlines
Eco Wave Power featured in second NVIDIA keynote within three months
June 2, 2026 8:31 AM - StreetInsider
Eco Wave Power Featured for Second Time in NVIDIA Founder and CEO Jensen Huang's GTC Keynote, as Company Advances Taiwan Wave Energy Project
June 2, 2026 8:30 AM - PR NewsWire
Wave Life Sciences to Present at Upcoming Investor Conferences
June 1, 2026 8:30 AM - StreetInsider
WAVE Life Sciences (WVE) PT Raised to $14 at Wells Fargo
May 20, 2026 5:44 AM - StreetInsider
Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1
May 19, 2026 9:50 AM - PR NewsWire
WAVE Life Sciences (WVE) Reiterated at Overweight by Cantor Fitzgerald on WVE-006 Data
May 19, 2026 6:56 AM - StreetInsider
WAVE Life Sciences (WVE) PT Lowered to $13 at H.C. Wainwright
May 19, 2026 6:46 AM - StreetInsider
Form 8-K Wave Life Sciences Ltd. For: May 18
May 18, 2026 4:52 PM - SEC Filing
Wave Life Sciences reports trial progress for AATD treatment
May 18, 2026 4:30 PM - StreetInsider
Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing
May 18, 2026 4:30 PM - Globe NewsWire
Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing
May 18, 2026 4:30 PM - StreetInsider
Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference
May 13, 2026 4:05 PM - StreetInsider
Form SCHEDULE 13G/A Wave Life Sciences Ltd. Filed by: Adage Capital Management, L.P.
May 13, 2026 9:22 AM - SEC Filing
Form DEF 14A Wave Life Sciences Ltd. For: Jun 22
May 7, 2026 4:02 PM - SEC Filing
Form SCHEDULE 13G/A Wave Life Sciences Ltd. Filed by: FMR LLC
May 6, 2026 11:41 AM - SEC Filing
Form PRER14A Wave Life Sciences Ltd.
May 1, 2026 4:22 PM - SEC Filing
WAVE Life Sciences (WVE) PT Lowered to $24 at Citi
May 1, 2026 4:23 AM - StreetInsider
Form 10-K/A Wave Life Sciences Ltd. For: Dec 31
April 30, 2026 4:20 PM - SEC Filing
WAVE Life Sciences (WVE) PT Lowered to $43 at Canaccord
April 30, 2026 6:35 AM - StreetInsider
WAVE Life Sciences (WVE) PT Lowered to $31 at B.Riley
April 29, 2026 11:32 AM - StreetInsider
Truist Securities Assumes WAVE Life Sciences (WVE) at Buy
April 29, 2026 2:51 AM - StreetInsider
RBC on WAVE Life Sciences (WVE): 'we continue to like the setup'
April 28, 2026 2:58 PM - StreetInsider
WAVE Life Sciences (WVE) PT Lowered to $19 at BofA Securities
April 28, 2026 1:13 PM - StreetInsider
WAVE Life Sciences (WVE) PT Lowered to $36 at Clear Street
April 28, 2026 12:49 PM - StreetInsider
Form 10-Q Wave Life Sciences Ltd. For: Mar 31
April 28, 2026 7:51 AM - SEC Filing
Form 8-K Wave Life Sciences Ltd. For: Apr 28
April 28, 2026 7:35 AM - SEC Filing
WAVE Life Sciences (WVE) Tops Q1 EPS by 19c
April 28, 2026 7:31 AM - StreetInsider
Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
April 28, 2026 7:30 AM - Globe NewsWire
Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition
April 22, 2026 8:30 AM - Globe NewsWire
Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026
April 22, 2026 8:30 AM - Globe NewsWire
Form DEFA14A Wave Life Sciences Ltd.
April 21, 2026 5:05 PM - SEC Filing
Form 8-K Wave Life Sciences Ltd. For: Apr 21
April 21, 2026 4:50 PM - SEC Filing
Wave Life Sciences schedules court hearing for US redomiciliation
April 21, 2026 4:01 PM - StreetInsider
Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States
April 21, 2026 4:01 PM - Globe NewsWire
Form 3 Wave Life Sciences Ltd. For: Apr 09 Filed by: Ingelsson Erik
April 17, 2026 9:00 PM - SEC Filing
Form 3 Wave Life Sciences Ltd. For: Apr 09 Filed by: Wright Christopher I
April 17, 2026 9:00 PM - SEC Filing
Form SCHEDULE 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
April 17, 2026 4:57 PM - SEC Filing
Form PRE 14A Wave Life Sciences Ltd. For: Apr 15
April 15, 2026 4:14 PM - SEC Filing
Form DEFA14A Wave Life Sciences Ltd.
April 15, 2026 4:12 PM - SEC Filing
Form 8-K Wave Life Sciences Ltd. For: Apr 15
April 15, 2026 4:08 PM - SEC Filing
Wave Life Sciences plans redomiciliation from Singapore to Delaware
April 15, 2026 4:01 PM - StreetInsider
Wave Life Sciences Announces Proposed Redomiciliation to the United States
April 15, 2026 4:01 PM - Globe NewsWire
WAVE Life Sciences (WVE) PT Lowered to $18 at H.C. Wainwright
April 14, 2026 6:44 AM - StreetInsider
WAVE Life Sciences (WVE) PT Lowered to $15 at RBC Capital
April 7, 2026 9:03 AM - StreetInsider
Increasing unusual call option volume: PROP AUTL TERN MKC PRGS CANE WTI WVE AMTX
March 31, 2026 9:50 AM - StreetInsider
Form SCHEDULE 13D/A Wave Life Sciences Ltd. Filed by: RA CAPITAL MANAGEMENT, L.P.
March 30, 2026 8:32 PM - SEC Filing
Form 4 Wave Life Sciences Ltd. For: Mar 26 Filed by: RA Capital Healthcare Fund LP
March 30, 2026 8:31 PM - SEC Filing
WAVE Life Sciences (WVE) PT Lowered to $15 at Wedbush, Removed from best Ideas List
March 27, 2026 6:55 AM - StreetInsider
WAVE Life Sciences (WVE) PT Lowered to $13 at Wells Fargo
March 27, 2026 6:51 AM - StreetInsider
RBC on WAVE Life Sciences (WVE): 't we continue to see a molecule that is pharmacologically active and remain optimistic'
March 27, 2026 5:04 AM - StreetInsider
WAVE Life Sciences (WVE) PT Lowered to $39 at Clear Street, 'we think ‘007 should find its optimal patient population'
March 26, 2026 4:21 PM - StreetInsider
Form 4 Wave Life Sciences Ltd. For: Mar 23 Filed by: TAKANASHI KEN
March 26, 2026 4:17 PM - SEC Filing
WAVE Life Sciences (WVE) PT Lowered to $25 at Leerink Partners
March 26, 2026 2:47 PM - StreetInsider
TD Cowen on Arrowhead Pharma (ARWR): 'We remain at Buy as the pipeline remains robust'
March 26, 2026 2:33 PM - StreetInsider
WAVE Life Sciences (WVE) PT Lowered to $18 at Jefferies
March 26, 2026 2:01 PM - StreetInsider
WAVE Life Sciences (WVE) PT Lowered to $21 at BofA Securities
March 26, 2026 12:30 PM - StreetInsider
B.Riley on WAVE Life Sciences (WVE): 'a ~60% intraday selloff that, in our view, is significantly overdone'
March 26, 2026 12:23 PM - StreetInsider
WAVE Life Sciences (WVE) PT Lowered to $12 at Raymond James
March 26, 2026 11:31 AM - StreetInsider
Jefferies on WAVE Life Sciences (WVE): 'near-term pressure on stock'
March 26, 2026 9:37 AM - StreetInsider
Leerink Partners on WAVE Life Sciences (WVE) after obesity data disappoints: selloff 'very overdone'
March 26, 2026 9:00 AM - StreetInsider
Jones Trading on WAVE Life Sciences (WVE) GLP-1: 'we still see the chance for utility in elderly or patients with metabolic disease'
March 26, 2026 8:55 AM - StreetInsider
Leerink on WAVE Life Sciences (WVE) Amid 52pct Collapse: 'The stock's reaction premarket... is very overdone in our opinion'
March 26, 2026 8:52 AM - StreetInsider
Oppenheimer on WAVE Life Sciences (WVE): 'we would be buyers any weakness'
March 26, 2026 8:20 AM - StreetInsider
Form 8-K Wave Life Sciences Ltd. For: Mar 26
March 26, 2026 7:41 AM - SEC Filing
Wave Life Sciences reports phase 1 obesity drug results
March 26, 2026 7:30 AM - StreetInsider
Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six
March 26, 2026 7:30 AM - StreetInsider
Jefferies on WAVE Life Sciences (WVE): 'We see reasonable bars for WVE's RNA editor to approach target protein levels'
March 25, 2026 11:56 AM - StreetInsider
WAVE Life Sciences (WVE) PT Raised to $27 at Mizuho
March 24, 2026 4:56 PM - StreetInsider
RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'
March 18, 2026 9:21 AM - StreetInsider
WAVE Life Sciences (WVE) PT Raised to $52 at Canaccord
March 10, 2026 6:38 AM - StreetInsider
Full Article List
